Ryan Savitz
2023
In 2023, Ryan Savitz earned a total compensation of $329.7K as Chief Financial Officer, Chief Business Officer and Treasurer at Dianthus Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $194,140 |
|---|---|
| Salary | $135,511 |
| Total | $329,651 |
Savitz received $194.1K in non-equity incentive plan, accounting for 59% of the total pay in 2023.
Savitz also received $135.5K in salary.
Rankings
In 2023, Ryan Savitz's compensation ranked 2,450th out of 3,006 executives tracked by ExecPay. In other words, Savitz earned more than 18.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,450 out of 3,006 | 19th |
Division Manufacturing | 1,375 out of 1,650 | 17th |
Major group Chemicals And Allied Products | 802 out of 918 | 13th |
Industry group Drugs | 782 out of 881 | 11th |
Industry Pharmaceutical Preparations | 562 out of 637 | 12th |
Source: SEC filing on April 11, 2024.
Savitz's colleagues
We found six more compensation records of executives who worked with Ryan Savitz at Dianthus Therapeutics in 2023.
2023
Stephen Mahoney
Dianthus Therapeutics
Former President, Chief Financial and Operating Officer
2023
Thomas Beetham
Dianthus Therapeutics
Chief Legal Officer
2023
Lisa Olson
Dianthus Therapeutics
Chief Scientific Officer
2023
Jason Gardner
Dianthus Therapeutics
Chief Executive Officer
2023
Marino Garcia
Dianthus Therapeutics
Chief Executive Officer
2023
Simrat Randhawa
Dianthus Therapeutics